MA42553A - Formulations à libération prolongée de flurbiprofène et de tramadol - Google Patents

Formulations à libération prolongée de flurbiprofène et de tramadol

Info

Publication number
MA42553A
MA42553A MA042553A MA42553A MA42553A MA 42553 A MA42553 A MA 42553A MA 042553 A MA042553 A MA 042553A MA 42553 A MA42553 A MA 42553A MA 42553 A MA42553 A MA 42553A
Authority
MA
Morocco
Prior art keywords
tramadol
flurbiprofen
sustained
release formulations
formulations
Prior art date
Application number
MA042553A
Other languages
English (en)
Inventor
Deniz Ömür Durgun
Zekiye Basak Hatirnaz
Akalin Nur Pehlivan
Ali Türkyilmaz
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret As filed Critical Sanovel Ilac Sanayi Ve Ticaret As
Publication of MA42553A publication Critical patent/MA42553A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA042553A 2016-04-28 2017-04-27 Formulations à libération prolongée de flurbiprofène et de tramadol MA42553A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201605504 2016-04-28
TR2016/05632A TR201605632A1 (tr) 2016-04-28 2016-05-02 Flurbi̇profen ve tramadolün yavaş salinimli kombi̇nasyonlari

Publications (1)

Publication Number Publication Date
MA42553A true MA42553A (fr) 2018-06-06

Family

ID=58638778

Family Applications (2)

Application Number Title Priority Date Filing Date
MA042552A MA42552A (fr) 2016-04-28 2017-04-27 Compositions pharmaceutiques de flurbiprofène et de tramadol
MA042553A MA42553A (fr) 2016-04-28 2017-04-27 Formulations à libération prolongée de flurbiprofène et de tramadol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA042552A MA42552A (fr) 2016-04-28 2017-04-27 Compositions pharmaceutiques de flurbiprofène et de tramadol

Country Status (4)

Country Link
US (1) US20170312236A1 (fr)
EP (1) EP3238713A1 (fr)
MA (2) MA42552A (fr)
TR (1) TR201605632A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11554112B2 (en) 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
TWI908716B (zh) * 2019-02-13 2025-12-21 愛爾蘭商伊泰倫醫療國際有限公司 β-內醯胺化合物及丙磺舒之組合及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339105B1 (en) 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
US20080031950A1 (en) * 2007-04-27 2008-02-07 Nectid Inc. Novel anelgesic combination
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination

Also Published As

Publication number Publication date
US20170312236A1 (en) 2017-11-02
TR201605632A1 (tr) 2017-11-21
MA42552A (fr) 2018-06-06
EP3238713A1 (fr) 2017-11-01

Similar Documents

Publication Publication Date Title
PT3523390T (pt) Utilização de composições à base de tetrafluoropropeno
EP3453938A4 (fr) Mécanisme de bouton de trépied et trépied
MA44725A (fr) Formulations d'un inhibiteur de lsd1
EP3509581A4 (fr) Formulations de (r
EP3298353A4 (fr) Réponses à des questions d'image multilingue
PT3548033T (pt) Compostos e respectivos métodos de utilização
EP3478215A4 (fr) Appareil orthodontique à autoligature
HUE052468T2 (hu) Arginázgátlók és terápiás alkalmazásaik
EP3332358A4 (fr) Imagerie à super-résolution d'interactions protéine-protéine
EP3250367A4 (fr) Étalonnage d'agent
EP3465453A4 (fr) Interface à nombre de broches réduit
DK3574135T3 (da) Fremgangsmåde og formulering til fremstilling af ligninfibre
MA44212A (fr) Prégabaline à libération prolongée contrôlée
DK3380525T3 (da) Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf
EP3425215A4 (fr) Structure à sillons et objet
EP3347334A4 (fr) Déshydrohalogénation d'hydrochlorofluorocarbones
EP3658683A4 (fr) Découverte d'épitopes à médiation par trogocytose
IL281976A (en) Anti-fgfr2 antibody formulations
EP3467365A4 (fr) Appareil à thermostat
EP3512521A4 (fr) Composition pharmaceutique de clozapine à libération prolongée
DK3678644T3 (da) Formuleringer af copanlisib
EP3323363A4 (fr) Ensemble ancrage à vis
DK3512518T3 (da) Buprenophinformuleringer med langvarig frigivelse
EP3955910A4 (fr) Formulations à libération prolongée
EP3471740A4 (fr) Compositions et méthodes d'utilisation de nanomédicaments à base d'albumine